z-logo
Premium
Synthesis and Biological Evaluation of New Quinazoline and Cinnoline Derivatives as Potential Atypical Antipsychotics
Author(s) -
Alvarado Mario,
Barceló María,
Carro Laura,
Masaguer Christian F.,
Raviña Enrique
Publication year - 2006
Publication title -
chemistry and biodiversity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 70
eISSN - 1612-1880
pISSN - 1612-1872
DOI - 10.1002/cbdv.200690001
Subject(s) - chemistry , affinities , quinazoline , cinnoline , dopamine receptor d2 , 5 ht receptor , stereochemistry , serotonin , receptor , selectivity , derivative (finance) , dopamine , combinatorial chemistry , medicinal chemistry , biochemistry , neuroscience , psychology , financial economics , economics , catalysis
Four new diaza analogues ( 14, 15, 23 , and 24 ) of the conformationally constrained aminobutyrophenone derivatives QF0104B ( 5 ) and QF0108B ( 6 ) were synthesized ( Schemes 2 and 3 ), and evaluated for their binding affinities ( Table ) towards the serotonin 5‐HT 2A and 5‐HT 2C , and the dopamine D 2 receptors. Among the new compounds, the quinazoline derivative 15 (=7‐{[4‐(4‐fluorobenzoyl)piperidin‐1‐yl]methyl}‐5,6,7,8‐tetrahydroquinazolin‐5‐one) exhibited the highest affinities towards the serotonin 5‐HT 2A and dopamine D 2 receptors, and it is in the borderline of potential atypical antipsychotics. The cinnoline derivative 23 (=7‐{[4‐(4‐fluorobenzoyl)piperidin‐1‐yl]methyl}‐5,6,7,8‐tetrahydro‐3‐methylcinnolin‐5‐one) displayed high selectivity in its binding profile towards the 5‐HT 2C compared to both the 5‐HT 2A and D 2 receptors.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom